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Abstract 
The conventional approach to identifying the defective gene in a family with an 
inherited disease is to find the disease locus through family studies. However the rapid 
development and decreasing cost of next generation sequencing facilitates a more direct 
approach. Here we report the identification of a frameshift mutation in LAMB3 as a 
cause of dominant hypoplastic amelogenesis imperfecta (AI). Whole exome sequencing 
of three affected family members and subsequent filtering of shared variants, without 
prior genetic linkage, sufficed to identify the pathogenic variant. Simultaneous analysis 
of multiple family members confirms segregation, enhancing the power to filter the 
genetic variation found and leading to rapid identification of the pathogenic variant. 
LAMB3 encodes a subunit of Laminin-5, one of a family of basement membrane 
proteins with essential functions in cell growth, movement and adhesion. Homozygous 
LAMB3 mutations cause junctional epidermolysis bullosa (JEB) and enamel defects are 
seen in JEB cases. However, to our knowledge, this is the first report of dominant AI 
due to a LAMB3 mutation in the absence of JEB. 
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Introduction 
Amelogenesis Imperfecta (AI) is the collective term given to a genetically 
heterogeneous group of inherited defects of tooth enamel biomineralisation. Typically 
all teeth of the primary and secondary dentitions are affected, with marked variations in 
clinical phenotypes that are influenced by the underlying genotypes1. The impact of AI 
on affected individuals and their families is considerable2. To date, mutations in 7 genes 
(AMELX, MIM 30039; ENAM, MIM 606585; KLK4, MIM 603767; MMP20, MIM 
604629; FAM83H, MIM 611927; WDR72, MIM 613214 and C4orf26, MIM 614829) 
have been shown to cause either autosomal dominant, autosomal recessive or X-linked 
AI in the absence of other co-segregating abnormalities3-9.  
Methods for identifying the defective gene in any given disorder generally 
involve identification of a disease locus followed by candidate gene sequencing. More 
recently next generation sequencing (NGS) has led to a hypothesis-null method of 
mutation identification through complete sequencing of exons at a locus in a single 
affected individual. With this approach a more manageable number of variants are 
highlighted after bioinformatic filtering than would be expected if examining the entire 
exome. These are then prioritised for segregation analysis, determination of frequency 
in control samples, analysis of evolutionary conservation and likely impact on protein 
function in order to determine the pathogenic variant.  
Here we report a further simplification of this approach, leading to the 
identification of a frameshift mutation in LAMININ-β3 (LAMB3; MIM 150310) in a 
family segregating non-syndromic dominant hypoplastic AI. Whole exome NGS of 
three affected individuals, without prior genetic linkage, proved sufficient to identify the 
causative change.  
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Patients and Methods 
Members of family AI-17, originating from Ireland, were recruited in 
accordance with the principles of the declaration of Helsinki, with informed consent and 
ethical approval. DNA samples were obtained from family members using either 
Oragene® DNA sample collection kits (DNA Genotek, Ontario, Canada) or via venous 
blood samples using conventional techniques. Screening of genes known to cause 
dominant AI (ENAM and FAM83H) was performed as previously described10. Whole 
exome sequencing was performed on a HiSeq2000 using the Nimblegen v2 chip by 
Otogenetics Corporation (Norcross, USA). Resulting data were analysed and annotated 
using the DNAnexus (https://dnanexus.com/) data storage and analysis facility. 
Additional bioinformatic analysis of variants was performed using PolyPhen2 
(http://genetics.bwh.harvard.edu/pph2/). The presence of potential variants was 
confirmed and segregation checked by PCR and Sanger sequencing using standard 
protocols. A multi-point Lod score was generated using Superlink Online 
(http://bioinfo.cs.technion.ac.il/superlink-online/). 
 
Results 
The proband of family AI-17 (arrowed in Fig.1A) presented with irregular 
hypoplastic AI and an autosomal dominant family history spanning four generations. 
Affected family members had experienced many symptomatic (e.g. frequent pain) and 
aesthetic problems with their teeth (Fig.1B). Some individuals had received extensive 
restorative dental care and required multiple dental extractions. Review of the medical 
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histories revealed no other health problems co-segregating with AI. In particular, no 
fragility, blistering or other skin problems were noted.   
The known dominant AI genes ENAM and FAM83H were screened and 
excluded by PCR and Sanger sequencing in affected individual III:2. We then 
hypothesized that whole exome sequencing of three distantly related, affected family 
members could allow the pathogenic mutation to be identified, without any prior 
mapping of a locus. Exonic DNA from individuals III:2, III:3 and IV:4 (indicated with * 
in Fig.1A) was therefore captured using a Nimblegen v2 exome reagent and clonally 
sequenced on a HiSeq2000 sequencer. The data generated are summarised in 
Supplementary Table 1.  
The variants identified in each sample were filtered to exclude those more than 
50 bp from an exon; known polymorphisms (variants listed in versions of dbSNP up to 
and including dbSNP129 or those with a minor allele frequency greater than 1%); and 
any variants which did not pass standard Genome Analysis Toolkit variant filters. Total 
variants remaining after each of these stages of filtering are presented in Supplementary 
Table 2. Next, homozygous changes were excluded in light of the clear dominant 
inheritance in the family, and the remaining variants in each sample were compared to 
identify changes shared by all three affected individuals sequenced. At this stage any 
variant not within an exon or consensus-splice sequence was excluded. In addition, two 
of the remaining variants were re-tested using Sanger sequencing and found to be 
absent, and were therefore assumed to have been artefacts of NGS. This left twelve 
variants to take forward for further analyses (Table 1).  
Of these, eight were present in dbSNP with a minor allele frequency (MAF) of 
greater than 0.1% and were therefore considered unlikely to be the cause of this rare 
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dominant disease, given that the frequency of all forms of AI is estimated to be only 
approximately 1/14,000 in the genetically heterogeneous US population11. The MAF for 
a ninth variant was unknown but its presence in both the Watson and Venter genomes 
suggests it is a benign SNP present in the normal population. One further variant was 
predicted to be non-pathogenic by bioinformatic prediction software PolyPhen2. A 3bp 
in-frame deletion in the HOMEZ gene (p.D547del; rs148005528) was excluded as it 
occurs within a run of eight aspartic acid residues, and four other 3bp deletion SNPs 
occur within in this run, each removing a single aspartic acid residue, suggesting that 
the deletion of a single residue is non-pathogenic.  
This left only a single variant, a frameshift in the LAMB3 gene (NM_000228 - 
c.3392_3393insG; p.E1133Gfs*27) on chromosome 1q32 (Fig.1C), as the potential 
cause of the disease phenotype. Homozygous LAMB3 mutations cause junctional 
epidermolysis bullosa (JEB) and enamel developmental defects are a universal finding 
in JEB, although severity and clinical expression vary widely12. This variant was 
therefore considered a strong candidate for the pathogenic mutation in this family. 
Further investigation of the exome sequences of affected members of AI-17 confirmed 
that no variants were present in the collagen type XVII, alpha 1 gene (COL17A1), 
mutations in which can act in concert with LAMB3 mutations to cause digenic JEB13. 
Sequencing of the LAMB3 variant using primers F:5’-
GTTGGGAGTCTTGGGGAGTC-3’ and R:5’-AAGCATTCCAACCCAATCTG-3’ in 
all available family members revealed perfect segregation with the disease phenotype 
(Fig.1A). Furthermore, the variant was excluded from 180 Caucasian control 
individuals. A Lod score of 2.3 was achieved using the LAMB3 variant as a genetic 
marker, assuming 100% penetrance and an allele frequency of 0.0001. 
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Discussion 
Current methods of gene identification generally require the mapping of a locus 
prior to Sanger sequencing or NGS. However, the wealth of data generated by NGS 
allow a range of techniques to be performed on just a single data set, leading to a shift in 
the methodological process of identification of disease-causing gene mutations. Here we 
show that by subjecting the more distantly related affected individuals within a pedigree 
to whole exome sequencing, the requirement for locus mapping is circumvented. Using 
this method, we were able to identify a novel heterozygous frameshift mutation in 
LAMB3, encoding a subunit of Laminin-5, as a cause of dominant hypoplastic AI.  
Recessive mutations in LAMB3 are already known to cause JEB, characterized 
by intense skin blistering arising within the lamina lucida of the basement membrane, 
caused by a failure of hemidesmosome formation between the epidermis and lamina 
densa14. Laminins are a family of network-forming trimeric proteins that are major 
constituents of the basal lamina, an extracellular matrix layer of the basement 
membrane. Laminin-5 consists of 3 polypeptides, alpha-3, beta-3, and gamma-2, 
encoded by the genes LAMA3 (MIM 600805), LAMB3, and LAMC2 (MIM 150292), 
respectively. Recessive mutations in these genes, and also in COL17A1 (MIM 113811), 
cause Herlitz (severe) and non-Herlitz (milder) JEB (MIM 226700)15, with LAMB3 
mutations accounting for around 80% of cases16. Digenic JEB has also been noted, in 
which compound heterozygous changes in COL17A1 combine with a heterozygous 
LAMB3 variant to cause JEB, though any two of the mutations described do not suffice 
to cause the disease13.  
Most JEB cases also have enamel defects, including those due to recessive 
LAMB3 mutations, though these defects vary in severity12. Furthermore, some 
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heterozygous carriers of COL17A1 and LAMA3 mutations display an AI phenotype, 
though it is not common17-19. No such cases have been reported for LAMB3 
heterozygotes. Additionally, Col-17 and Lama3 knockout mice have defects in 
amelogenesis, with further examination revealing defects in Tomes’ processes causing 
disturbed enamel matrix secretion and malformed enamel rods20,21. While a Lamb3 
mouse model exists, recessive mutants died within 24 hours of birth and no examination 
of teeth was performed22. 
The mutation identified in this study is a premature termination codon in the 
final exon of LAMB3. Nonsense mutations in the last exon of a gene are not thought to 
cause nonsense-mediated decay (NMD) since an exon/exon junction upstream of the 
mutation is required to bind NMD initiation factors23. It therefore seems likely that a 
mutated protein will be expressed, with the C-terminal 40 amino acids of this 1172 
amino acid protein replaced by 27 incorrect amino acids. The C-terminus of LAMB3 
primarily consists of an α-helical domain responsible for Laminin-5 subunit assembly24 
(Fig.1D). The phenotype observed may therefore be a result of gain of function due to 
the mutant protein partially inhibiting the assembly of the heterotrimeric Laminin-5 
complex. Interestingly there is no evidence in the literature that parents of JEB children 
with LAMB3 mutations, themselves heterozygous carriers of LAMB3 mutations, have 
AI. However, many of the mutations described in JEB cases are nonsense mutations 
near the amino-terminus, which are more likely than the mutation described herein to 
cause a complete knock-out of the gene. It therefore seems reasonable to speculate that 
the mutation described herein is unusual in its effect, acting as a dominant gain-of-
function mutation to cause AI, while the majority of LAMB3 mutations are knock-outs, 
causing no phenotype in carriers while manifesting as JEB with enamel defects in 
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homozygotes. Dental examinations in carrier parents of JEB cases due to a range of 
LAMB3 mutations would further test this hypothesis. 
Amelogenesis involves three ameloblast stages; pre-secretory, secretory and 
maturation. In mice, Laminin-5 expression is observed mainly within secretory 
ameloblasts, particularly in Tomes’ processes, and in the enamel matrix, highlighting its 
requirement in the secretory stage of amelogenesis25,26. This correlates with the 
hypoplastic AI phenotype due to a reduced enamel matrix volume observed in the 
family investigated. Furthermore, Laminin-5 has been shown to be located on the apical 
and basal edge of secretory ameloblasts, suggesting it is required to anchor ameloblasts 
to the enamel matrix25,27. A defect in Laminin-5 is likely to lead to failure of transport 
across the cell-enamel matrix junction. Additionally, correct anchoring and arrangement 
of ameloblasts is required for crystal rod orientation, structure and mineralisation26. 
Loss of Laminin-5 function is therefore likely to interrupt the secretory stage of 
amelogenesis, leading to a reduction in the volume of enamel matrix and impaired 
crystal rod growth. 
 In summary, we have identified a frame-shift mutation at the extreme C-
terminus of LAMB3, an integral member of the Laminin-5 heterotrimer, as a cause of 
dominant hypoplastic AI. The AI phenotype observed is consistent with a failure in the 
secretory stage of amelogenesis due to poor ameloblast adhesion to the secreted enamel 
matrix. In addition we have shown that whole exome sequencing of three distantly 
related family members can suffice to identify the causative mutation in a dominant 
family. 
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Figure Legend 
Figure 1: A - Pedigree of family AI-17 illustrating segregation of the wild-type (+) and 
variant (-) alleles for the LAMB3 variant with the disease phenotype. The proband is 
marked with an arrow. Individuals who were whole exome sequenced are marked with 
an asterix. B - Clinical phenotype observed in the proband at 3 years of age. A 
generalised, irregular hypoplastic AI is observed with small islands of enamel evident 
on close inspection (arrows).  These are absent from where the teeth occlude indicating 
that the clinical phenotype has probably been modified by post-eruptive changes.  The 
panoramic radiograph of the proband confirms that the enamel is hypoplastic on 
formation. C - Electropherogram showing the LAMB3 mutation and wild-type sequence. 
D - Location of the LAMB3 change with respect to the Laminin-5 heterotrimer (based 
on Nakano et al.28). 
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Variant Gene Protein change dbSNP ID Comment 
Chr1:204192659 
G > A 
PLEKHA6 
(NM_014935) 
Missense 
p.A1029V 
rs145148095 Allele Freq. > 0.1% 
     
Chr1:209788740 
insC 
LAMB3 
(NM_000282) 
Frameshift 
p.E1133Gfs*27 
None 
 
Causes JEB, enamel 
hypoplasia often observed 
     
Chr2:17962993 
delAAGTT 
GEN1 
(NM_001130009) 
Frameshift rs149936944 Allele Freq. > 0.1% 
     
Chr3:43095112  
G > A 
FAM198A 
(NM_001129908) 
Missense  
p.E464K 
rs184462308 Allele Freq. > 0.1% 
     
Chr5:96124300  
C > T 
ERAP1 
(NM_001040458) 
Missense 
p.R538K 
rs142305981 PolyPhen2 = 0 
     
Chr5:102888040  
C > T 
NUDT12 
(NM_031438) 
Missense  
p.A386T 
rs139189967 Allele Freq. > 0.1% 
     
Chr5:132556523  
C > T 
FSTL4 
(NM_015082) 
Missense 
p.D459N 
rs140221506 Allele Freq. > 0.1% 
     
Chr8:41791414  
C > T 
KAT6A 
(NM_001099412) 
Missense 
p.A1442T 
rs113195648 Allele Freq. > 0.1% 
     
Chr9:119976883  
A > T 
ASTN2 
(NM_014010) 
Missense  
p.S257T 
rs139148246 Allele Freq. > 0.1% 
     
Chr12:122359397 
insGAGGAGGAGG
AGAAA 
WDR66 
(NM_001178003) 
Insertion rs67558673 Allele Freq. > 0.1% 
     
Chr14:23744800 
delCAT 
HOMEZ 
(NM_020834) 
Deletion 
p.547del 
rs148005528 Within a simple repeat 
containing additional 3-bp 
deletion SNPs.  
     
Chr17:6928019 
insCAG 
BCL6B 
(NM_181844) 
Insertion rs66978918 Present in Venter and Watson 
genomes 
     
 
Table 1 – The list of variants after filtration. All twelve variants remaining after 
filtration were individually assessed for pathogenicity and excluded or highlighted as a 
good candidate based on the entry in the comments column. 
